$ACLS

Sutton Todd sold $320K of ACLS

Sutton Todd (VP Corporate Controller) sold 2,000 shares of AXCELIS TECHNOLOGIES INC (ACLS) at $159.99 ($0.32M total) on 2026-05-27.

Original reporting
SEC EDGAR · Sutton Todd
Published May 28, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:48 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACLS
Neutral
medium confidence
Mentioned
$ACLS
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACLSNeutralLow
01

Why it matters

The only new information is the disclosed sale details (2,000 shares at $159.99) and the stated lack of a 10b5-1 plan in the filing text provided.

02

Market read

Traders may note insider selling as a sentiment datapoint, but there is no accompanying fundamental update in the text.

03

What to watch

The filing does not state motivations, and the article provides only one sale transaction without context on prior insider activity or total holdings changes over time.

Relevance 4/10Novelty 3/10Timing: Form 4 filed 2026-05-28, transaction dated 2026-05-27

Background

The article is an SEC Form 4 insider transaction disclosure for Axcelis Technologies, reported by VP Corporate Controller Sutton Todd.

Company-level read

Ticker impact

$ACLSNeutralMedium confidence
Context

Axcelis Technologies insider Sutton Todd sold 2,000 shares at $159.99 on 2026-05-27, per a Form 4 filed 2026-05-28.

Expected impact

Likely limited near-term impact; any effect should be small and short-lived unless follow-on selling emerges.

Evidence & confidence

Form 4 insider sales are common and this filing provides no new company-specific operational or financial information. The absence of a stated 10b5-1 plan can raise attention, but the disclosed size ($319,980) is modest relative to typical market moves.

Market effects

No clear sector read-through from a single insider sale.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification or personal liquidity needs, not a bearish signal, especially since insider transactions are often pre-planned even when not explicitly labeled as 10b5-1.

Key entities

  • Axcelis Technologies Inc

    Public company subject of the Form 4 insider sale disclosure.

  • Sutton Todd

    VP Corporate Controller who sold 2,000 shares open-market.

Related articles

$ACLSHigh

AXCELIS TECHNOLOGIES INC (ACLS): Results of Operations and Financial Condition

AXCELIS TECHNOLOGIES INC (ACLS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622315d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 News Release Axcelis Announces Financial Results for Second Quarter 2026 Q2 2026 Highlights: · Revenue of $215.2 million · GAAP Gross Margin of 42.4%, and Non-GAAP Gross Margin of 42.7% · GAAP Operating Margin of 9.4% and

$ACLSMedAI 8/10

Axcelis Announces Financial Results for Second Quarter 2026

Axcelis Technologies (Nasdaq: ACLS) reported Q2 2026 revenue of $215.2 million, GAAP gross margin 42.4% and non-GAAP gross margin 42.7%. GAAP diluted EPS was $0.75 and non-GAAP diluted EPS $1.06. The company guided Q3 2026 revenue to about $230 million and GAAP EPS to about $0.76. It also said it expects year-over-year revenue growth in 2026 and plans to close its pending Veeco merger in H2 2026.

$ACLSMedAI 8/10

If You Like Micron Technology, You Might Love This Other Super Semiconductor Stock

Micron Technology’s reported 700% stock gain over the past year reflects strong demand for high-bandwidth memory used in data centers for AI. The article says Axcelis Technologies supplies ion implantation machines used early in chip manufacturing, and that memory makers expanding capacity should increase equipment orders. Axcelis reported $199 million Q1 revenue (+3% y/y); memory is about one-third of sales. Consensus forecasts $842 million revenue in 2026 and $921 million in 2027.